CMTA Announces New Center of Excellence in the United Kingdom
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease…
Lower Extremity Review
Lower Extremity Review is a monthly magazine that informs healthcare practitioners on current developments in the diagnosis, treatment, and prevention of injuries and conditions affecting the lower extremities, including CMT….
Be an INNERVATOR! Join the CMTA Monthly Giving Program
…Life-changing initiatives like Camp Footprint, treatment-focused research, and invaluable educational initiatives depend on steady, reliable support from committed and reliable donors. If you want to make a lasting difference in…
Gilles Bouchard Takes Helm of CMTA Board
…that while he is “excited and delighted” with the progress made by the CMTA’s STAR research program, there’s still much work to be done before a first drug treatment for…
2018_Winter_CMTA_Report
…consulted for treatment. Neuropathic and musculoskeletal pain are different in nature, and different strategies can be used to manage them. Cramps can be persistent, but, unfortunately, evidence is lacking on…
2021_Summer_ CMTA_Report
www.cmtausa.org SUMMER 2021 CMTATHE REPORT Food Additive Treatment for 1X Managing CMT Symptoms with Nutrition An Old Man’s Journey with CMT7 14 21> > > “ N O M A…
2021_Summer_CMTA_Report
www.cmtausa.org SUMMER 2021 CMTATHE REPORT Food Additive Treatment for 1X Managing CMT Symptoms with Nutrition An Old Man’s Journey with CMT7 14 21> > > “ N O M A…
CMTA_2020_Annual_Report
…projects, it is important to keep in mind that we have a clear pathway for treatment of CMT2 type neuropathies that affect motor neurons. The recently approved AAV treatment for…
CMTA-STAR Alliance Partner NMD Pharma Publishes Transformative Study on Charcot-Marie-Tooth Disease
…According to the company, treatment with the company’s novel CIC-1 inhibitor NMD670 improved muscle function in preclinical models, marking a critical step toward developing therapies for the CMT community. “This…
The CMTA Is Accelerating Research Through Gene Therapy
…is to transform it into effective treatments for people living with CMT. Given the increased feasibility and applicability of gene therapy to CMT, the CMTA hosted a Gene Therapy Workshop…